Lingyan Xu

4.0k total citations · 1 hit paper
105 papers, 2.2k citations indexed

About

Lingyan Xu is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Lingyan Xu has authored 105 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 32 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Lingyan Xu's work include Adipose Tissue and Metabolism (29 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Lingyan Xu is often cited by papers focused on Adipose Tissue and Metabolism (29 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Lingyan Xu collaborates with scholars based in China, United States and France. Lingyan Xu's co-authors include Xinran Ma, Elisabetta Mueller, Oksana Gavrilova, Wenjun Zhao, Alessia Bagattin, Dongmei Wang, Toren Finkel, Monica C. Skarulis, Jie Liu and Anna Teresa Alberobello and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lingyan Xu

101 papers receiving 2.2k citations

Hit Papers

Local hyperthermia therapy induces browning of white fat ... 2022 2026 2023 2024 2022 40 80 120

Peers

Lingyan Xu
Jian Wu China
Zhi Yang China
Tong Wu China
Sokrates Stein Switzerland
Fei Li China
Danielle Kamato Australia
Lingyan Xu
Citations per year, relative to Lingyan Xu Lingyan Xu (= 1×) peers Xiaoqiang Tang

Countries citing papers authored by Lingyan Xu

Since Specialization
Citations

This map shows the geographic impact of Lingyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Xu more than expected).

Fields of papers citing papers by Lingyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Xu. The network helps show where Lingyan Xu may publish in the future.

Co-authorship network of co-authors of Lingyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Xu. A scholar is included among the top collaborators of Lingyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Xu. Lingyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Meiyao, Shuang Liu, Yinzhao Zhong, et al.. (2025). Zinc finger protein ZNF638 in brown fat deteriorates type 1 diabetes via retinol binding protein 4. Science Bulletin. 71(3). 505–509.
2.
Xiang, Danfeng, Xiangqi Zhang, Shuai Zhao, et al.. (2025). Marsdenia tenacissima extract accelerates ferroptosis of osteosarcoma cells by upregulating HO-1 and activating mitophagy. Journal of Ethnopharmacology. 350. 120055–120055. 1 indexed citations
3.
Yuan, Wei, et al.. (2025). Dynamic analysis of floating railway slab tracks on curves and long inclines. KSCE Journal of Civil Engineering. 30(1). 100335–100335.
5.
Wang, Ying, et al.. (2024). The interaction mechanism of tepotinib and α-glucosidase: A prelude to control type 2 diabetes mellitus. Arabian Journal of Chemistry. 17(7). 105802–105802. 4 indexed citations
7.
Zheng, Xiaoyu, et al.. (2024). A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191. Hereditas. 161(1). 36–36. 1 indexed citations
8.
Guo, Yuhan, Xiaozhen Guo, Ziqi Liu, et al.. (2024). Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice. Advanced Science. 12(2). e2411015–e2411015. 6 indexed citations
9.
Xu, Lingyan, et al.. (2024). P‐glycoprotein‐mediated herb–drug interaction evaluation between Tenacissoside G and paclitaxel. Biomedical Chromatography. 38(10). e5984–e5984. 1 indexed citations
10.
Xu, Lingyan, Yi Zou, Shushan Ge, et al.. (2024). IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects. The Journal of Immunology. 212(7). 1232–1243. 4 indexed citations
11.
Xiang, Danfeng, Quanjun Yang, Lingyan Xu, et al.. (2024). Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma. BMC Complementary Medicine and Therapies. 24(1). 67–67. 3 indexed citations
12.
Li, Yu, Yankang Zhang, Dongmei Wang, et al.. (2023). Rna M6a Methylation Regulates Glycolysis of Beige Fat and Contributes to Systemic Metabolic Homeostasis. Advanced Science. 10(25). e2300436–e2300436. 15 indexed citations
13.
Guo, Xiaozhen, Jiawen Wang, Hualing Xu, et al.. (2023). Obesity induced disruption on diurnal rhythm of insulin sensitivity via gut microbiome-bile acid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(1). 159419–159419. 6 indexed citations
14.
Xie, Haoran, Lingyan Xu, & Bin Yan. (2023). Mechanical Properties of Ballastless Track Considering Freeze–Thaw Deterioration Damage. Mathematics. 11(10). 2289–2289. 4 indexed citations
15.
Li, Yu, Dongmei Wang, Yankang Zhang, et al.. (2022). Local hyperthermia therapy induces browning of white fat and treats obesity. Cell. 185(6). 949–966.e19. 141 indexed citations breakdown →
16.
Wei, Bin, Lingyan Xu, Wenjie Guo, et al.. (2021). SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS–STING Activation and Chemotherapeutic Sensitivity in Colon Cancer. Cancer Research. 81(12). 3215–3228. 65 indexed citations
17.
Gu, Yanhong, Lijun Xue, Fuxi Zhen, et al.. (2020). 175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC). Annals of Oncology. 31. S1307–S1308. 16 indexed citations
18.
Ma, Xinran, Lingyan Xu, & Elisabetta Mueller. (2016). Forkhead box A3 mediates glucocorticoid receptor function in adipose tissue. Proceedings of the National Academy of Sciences. 113(12). 3377–3382. 19 indexed citations
19.
Ma, Xinran, Lingyan Xu, Oksana Gavrilova, & Elisabetta Mueller. (2014). Role of forkhead box protein A3 in age-associated metabolic decline. Proceedings of the National Academy of Sciences. 111(39). 14289–14294. 57 indexed citations
20.
Xu, Lingyan, et al.. (2013). Preparation and Electrochemical Properties of SiO_2/PVDF-HFP/PP Non-Woven Composite Membrane Used for Lithium-Ion Battery. 29(1). 175–178. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026